dysphagia |
Disease ID | 1277 |
---|---|
Disease | dysphagia |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:17) C0038454 | stroke | 60 C0030193 | pain | 28 C0032285 | pneumonia | 23 C0032290 | aspiration pneumonia | 20 C0162429 | malnutrition | 17 C0002736 | amyotrophic lateral sclerosis | 8 C0152018 | esophageal carcinoma | 7 C0014848 | achalasia | 6 C0221163 | motor disorders | 3 C0426768 | o sign | 3 C1956089 | osteophytes | 3 C1839611 | n syndrome | 2 C0422833 | ent symptoms | 2 C0014858 | esophageal dysmotility | 1 C0014852 | esophageal disorders | 1 C2004632 | aberrant right subclavian artery | 1 C0587246 | limb weakness | 1 |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:3) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs121912438 | 19495873 | 6647 | SOD1 | umls:C0011168 | BeFree | We recently established that the SOD1-G93A transgenic mouse is a suitable model for oral-stage dysphagia in amyotrophic lateral sclerosis (ALS). | 0.000542884 | 2010 | SOD1 | 21 | 31667299 | G | C |
rs2267437 | 19251090 | 2547 | XRCC6 | umls:C0011168 | GAD | [Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes.] | 0.002367032 | 2009 | XRCC6;DESI1 | 22 | 41620695 | C | G |
rs861539 | 19251090 | 7517 | XRCC3 | umls:C0011168 | GAD | [Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes.] | 0.002367032 | 2009 | KLC1;XRCC3 | 14 | 103699416 | G | A |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:20) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0011168 | chlorpromazine | D002746 | 50-53-3 | deglutition disorders | MESH:D003680 | marker/mechanism | 4247303 | ||
C0011168 | cisapride | D020117 | 81098-60-4 | deglutition disorders | MESH:D003680 | marker/mechanism | 7723193 | ||
C0011168 | clozapine | D003024 | 5786-21-0 | deglutition disorders | MESH:D003680 | marker/mechanism | 7962689 | ||
C0011168 | digoxin | D004077 | 20830-75-5 | deglutition disorders | MESH:D003680 | marker/mechanism | 2039889 | ||
C0011168 | fosinopril | D017328 | 98048-97-6 | deglutition disorders | MESH:D003680 | marker/mechanism | 17245835 | ||
C0011168 | gemcitabine | C056507 | 103882-84-4 | deglutition disorders | MESH:D003680 | marker/mechanism | 9500323 | ||
C0011168 | haloperidol | D006220 | 52-86-8 | deglutition disorders | MESH:D003680 | marker/mechanism | 17024549 | ||
C0011168 | haloperidol | D006220 | 52-86-8 | deglutition disorders | MESH:D003680 | therapeutic | 17484951 | ||
C0011168 | lorazepam | D008140 | 846-49-1 | deglutition disorders | MESH:D003680 | therapeutic | 17484951 | ||
C0011168 | methotrexate | D008727 | 1959/5/2 | deglutition disorders | MESH:D003680 | marker/mechanism | 16314998 | ||
C0011168 | methysergide | D008784 | 361-37-5 | deglutition disorders | MESH:D003680 | marker/mechanism | 6807440 | ||
C0011168 | omeprazole | D009853 | 73590-58-6 | deglutition disorders | MESH:D003680 | therapeutic | 10566755 | ||
C0011168 | prochlorperazine | D011346 | 58-38-8 | deglutition disorders | MESH:D003680 | marker/mechanism | 20486582 | ||
C0011168 | pyridoxine | D011736 | - | deglutition disorders | MESH:D003680 | therapeutic | 20167372 | ||
C0011168 | tacrolimus | D016559 | 109581-93-3 | deglutition disorders | MESH:D003680 | marker/mechanism | 12819864 | ||
C0011168 | tetrabenazine | D013747 | 58-46-8 | deglutition disorders | MESH:D003680 | marker/mechanism | 132600 | ||
C0011168 | thiethylperazine | D013847 | 1420-55-9 | deglutition disorders | MESH:D003680 | marker/mechanism | 16101941 | ||
C0011168 | valproic acid | D014635 | 99-66-1 | deglutition disorders | MESH:D003680 | marker/mechanism | 20204907 | ||
C0011168 | vincristine | D014750 | - | deglutition disorders | MESH:D003680 | marker/mechanism | 10942065 | ||
C0011168 | ziprasidone | C092292 | 146939-27-7 | deglutition disorders | MESH:D003680 | marker/mechanism | 18305296 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |